Dipanjan Ghosh Selected Research

glucogallin

1/2022

A Short Review on Glucogallin and its Pharmacological Activities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dipanjan Ghosh Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 08/2006
3	COVID-19 01/2022 - 01/2021
2	Lymphoma (Lymphomas) 01/2009 - 01/2007
1	Glaucoma 01/2022
1	Cataract (Cataracts) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Virus Diseases (Viral Diseases) 10/2021
1	Diabetes Mellitus 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Liver Neoplasms (Liver Cancer) 01/2019
1	Cholera 12/2016
1	Diarrhea 12/2016
1	Infections 03/2010
1	HIV Infections (HIV Infection) 03/2010

Drug/Important Bio-Agent (IBA)

2	AntibodiesIBA 03/2010 - 01/2009
2	abrus agglutininIBA 01/2007 - 01/2007
1	Free RadicalsIBA 01/2022
1	glucogallinIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	AntioxidantsIBA 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 10/2021
1	Bromocriptine (Parlodel)FDA LinkGeneric 01/2021
1	A-Form DNA (A-DNA)IBA 01/2020
1	astrakurkuroneIBA 01/2019
1	SesquiterpenesIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2016
1	CalciumIBA 12/2016
1	AnoctaminsIBA 12/2016
1	Ace toxinIBA 12/2016
1	Peptides (Polypeptides)IBA 03/2010
1	Neutralizing AntibodiesIBA 03/2010
1	Immunoglobulin A (IgA)IBA 03/2010
1	AntigensIBA 01/2009
1	AgglutininsIBA 01/2007
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2007
1	Therapeutic UsesIBA 01/2007
1	Plant LectinsIBA 01/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2007
1	Immunologic Factors (Immunomodulators)IBA 08/2006
1	Proteoglycans (Proteoglycan)IBA 08/2006

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2007
1	Immunomodulation 01/2007